Samuel Herschkowitz is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in Jul 2016: Serenity Pharmaceuticals LLC (Brooklyn, NY — pharmaceuticals — 2016; $7.89M reported sold to 20 investors).
What this means One deal on file with the SEC, filed Jul 2016. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Alain Kodsi (1 shared filing) and Steven Etkind (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Samuel. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Samuel Herschkowitz and found 2 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "SAMUEL HERSCHKOWITZ" (A6) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.